Assisted dying Bill reintroduced to Parliament The Terminally Ill Adults (End of Life) Bill has been reintroduced by Lauren Edwards, Labour MP for Rochester and Strood.…
Janet Morrison: ‘Any contract reform is likely to have winners and losers’ As details of the new pharmacy contract hit the headlines, Janet Morrison talks through the rationale behind the details and what the sector can expect in coming months.…
Regulator investigating pharmacists following report on gender prescribing at GP practice Exclusive: The General Pharmaceutical Council said it opened its investigation after a report revealed how “potential harm” had been caused to 78 children and young people seeking support for gender dysphoria or incongruence.…
The impact of pharmacist-led medication intervention on patient perception and satisfaction following new acute coronary syndrome diagnosis prior to hospital discharge Cardiovascular disease is a major cause of morbidity and mortality, with acute coronary syndrome (ACS) remaining the leading cause of hospital admissions in the UK1,2. Strict adherence to the national guideline directed pharmacotherapy for secondary prevention of ACS is vital to improve patien…
The Critical Medicines Act: can the UK manage supply problems with the EU’s ‘safety belt’? Pharmacy leaders are hopeful that the Critical Medicines Act will help to alleviate medicines shortages in the UK, which have been rumbling on for several years.…
Regulator vows to prioritise racism review recommendations General Pharmaceutical Council chief executive, Kathie Cashell, said “urgent, demonstrable and visible action is needed by all leaders”, following the publication of the Mann review.…
Early-onset type 2 diabetes mellitus: identification and management An overview of early-onset type 2 diabetes mellitus, including its pathophysiology, diagnosis and management, as well as approaches for younger adults.…
Everything you need to know about the 2026/2027 community pharmacy contract Community pharmacies in England have received a 10% uplift in funding for 2026/2027 — a greater annual increase than other parts of the NHS. However, pharmacy representatives say it still falls short of reversing years of underfunding, stabilising the sector or supporting growing demands on the ne…
Office of Health Economics warns that contract margin write-off could be too low Exclusive: Thinktank says that £239m margin write-off agreed as part of the 2026/2027 pharmacy contract is “on the lower end of what is needed”.…
MS drug found to benefit patients with more advanced disease Researchers reported that ocrelizumab significantly reduced the risk of disability worsening in wheelchair-dependent patients.…
